Stockholders' Equity and Redeemable Convertible Preferred Stock (Tables)

3 Months Ended

Mar. 31, 2017

Stockholders' Equity Note [Abstract]

Schedule of designated separate series of capital stock

The Company had designated separate series of its capital stock as of March 31, 2017 and December 31, 2016 as summarized below:

	Number of Shares Issued
	and Outstanding as of
	March 31, 2017		December 31, 2016		Par Value		Conversion Ratio
Series "A"		-		-	$	0.0001	N/A
Series "C"		-		-		0.0001	0.05:1
Series “D"		4,725		4,725		0.0001	0.53:1
Series “D-1"		834		834		0.0001	0.53:1
Series “F-1"		-		-		0.0001	0.05:1
Series “H"		-		-		0.0001	0.53:1
Series “I”		-		-		0.0001	1.05:1
Series “J”		-		-		0.0001	0.05:1
Series “K”		-		-		0.0001	263.16:1

Schedule of warrant activity

A summary of warrant activity for the three months ended March 31, 2017 is presented below:

	Warrants		Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2016		1,250,311	$	9.21	$	-		3.91
Outstanding as of March 31, 2017		1,250,311	$	9.21				3.67
Exercisable as of March 31, 2017		1,250,311	$	9.21	$	-		3.67

Schedule of fair value of options granted

A summary of option activity under the Company’s employee stock option plan for the three months ended March 31, 2017 is presented below:

	Number of Shares		Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2016		310,091	$	82.25	$	-		4.1
Employee options granted		-		-		-		-
Outstanding as of March 31, 2017		310,091	$	82.25	$	-		3.9
Options vested and expected to vest		310,091	$	82.25	$	-		3.9
Options vested and exercisable		302,199	$	84.35	$	-		3.8

A summary of option activity under the Company’s non-employee stock option plan for the three months ended March 31, 2017 is presented below:

	Number of Shares		Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2016		2,893	$	98.07	$	-		4.4
Non-employee options granted		-		-		-		-
Outstanding as of March 31, 2017		2,893	$	98.07	$	-		4.2
Options vested and expected to vest		2,893	$	98.07	$	-		4.2
Options vested and exercisable		2,893	$	98.07	$	-		4.2

Schedule of option activity

Stock-based compensation for the three months ended March 31, 2017 and 2016 was comprised of the following ($ in thousands):

	For the Three Months Ended March 31,
	2017		2016
Employee stock option awards	$	4	$	1
Non-employee restricted stock awards		-		130
Total compensation expense	$	4	$	131